Introduction: The search for an HIV cure involves important behavioural and social
processes that complement the domains of biomedicine. However, the field has yet to tap …

Introduction The question of what motivates people to participate in research is particularly
salient in the HIV field. While participation in HIV research was driven by survival in the …

Strategies to control HIV in the absence of antiretroviral therapy are needed to cure HIV.
However, such strategies will require analytical treatment interruptions (ATIs) to determine …

Though antiretroviral therapy is the standard of care for people living with HIV, its treatment
limitations, burdens, stigma and costs lead to continued interest in HIV cure research. Early …

Introduction Biomedical research towards an HIV cure is advancing in the United States and
elsewhere, yet little is known about perceptions of risks and benefits among potential study …

Most people living with HIV (PLHIV) with reliable access to antiretroviral treatment (ART)
have a life expectancy similar to uninfected populations. Despite this, HIV can negatively …

Participation in HIV cure-related clinical trials that involve antiretroviral treatment (ART)
interruption may pose substantial individual risks for people living with HIV (PLHIV) without …

Acceptance and willingness to care for people living with HIV‐AIDS (PLHA) in society is still
a concern. The purpose of this study is to analyse the determinants of willingness to care for …

Currently, much of early phase HIV cure research involves unknown and potentially serious
risks, with little or no chance of direct health benefits. During informed consent, researchers …

There are two concurrent and novel major research pathways toward strategies for HIV
control:(1) long-acting antiretroviral therapy (ART) formulations and (2) research aimed at …